Literature DB >> 15623855

Community involvement in developing policies for genetic testing: assessing the interests and experiences of individuals affected by genetic conditions.

Sarah E Gollust1, Kira Apse, Barbara P Fuller, Paul Steven Miller, Barbara B Biesecker.   

Abstract

Because the introduction of genetic testing into clinical medicine and public health creates concerns for the welfare of individuals affected with genetic conditions, those individuals should have a role in policy decisions about testing. Mechanisms for promoting participation range from membership on advisory committees to community dialogues to surveys that provide evidence for supporting practice guidelines. Surveys can assess the attitudes and the experiences of members of an affected group and thus inform discussions about that community's concerns regarding the appropriate use of a genetic test. Results of a survey of individuals affected with inherited dwarfism show how data can be used in policy and clinical-practice contexts. Future research of affected communities' interests should be pursued so that underrepresented voices can be heard.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2005        PMID: 15623855      PMCID: PMC1449847          DOI: 10.2105/AJPH.2003.025734

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  78 in total

1.  Living with achondroplasia: attitudes toward population screening and correlation with quality of life.

Authors:  Sarah E Gollust; Richard E Thompson; Holly C Gooding; Barbara B Biesecker
Journal:  Prenat Diagn       Date:  2003-12-15       Impact factor: 3.050

2.  Power to the people? Restoring citizen participation.

Authors:  James A Morone; Elizabeth H Kilbreth
Journal:  J Health Polit Policy Law       Date:  2003 Apr-Jun       Impact factor: 2.265

3.  Living with achondroplasia in an average-sized world: an assessment of quality of life.

Authors:  Sarah E Gollust; Richard E Thompson; Holly C Gooding; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2003-08-01       Impact factor: 2.802

Review 4.  Ethical, legal, and social implications of genomic medicine.

Authors:  Ellen Wright Clayton
Journal:  N Engl J Med       Date:  2003-08-07       Impact factor: 91.245

Review 5.  Methodology for measuring health-state preferences--III: Population and context effects.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

Review 6.  Prenatal genetic testing and screening: constructing needs and reinforcing inequities.

Authors:  A Lippman
Journal:  Am J Law Med       Date:  1991

7.  One worked; the other didn't.

Authors:  L Roberts
Journal:  Science       Date:  1990-01-05       Impact factor: 47.728

8.  Genetic counseling -- the postcounseling period: II. Making reproductive choices.

Authors:  A Lippman-Hand; F C Fraser
Journal:  Am J Med Genet       Date:  1979

9.  The problem of discrimination in health care priority setting.

Authors:  D C Hadorn
Journal:  JAMA       Date:  1992-09-16       Impact factor: 56.272

10.  At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan.

Authors:  D S Markel; A B Young; J B Penney
Journal:  Am J Med Genet       Date:  1987-02
View more
  8 in total

1.  Commentary: a sociologist's view on community genetics.

Authors:  Aviad E Raz
Journal:  J Community Genet       Date:  2010-02-25

2.  Using qualitative and quantitative strategies to evaluate knowledge and perceptions about sickle cell disease and sickle cell trait.

Authors:  Marsha J Treadwell; Lakenya McClough; Elliott Vichinsky
Journal:  J Natl Med Assoc       Date:  2006-05       Impact factor: 1.798

Review 3.  Public willingness to participate in and public opinions about genetic variation research: a review of the literature.

Authors:  Rene Sterling; Gail E Henderson; Giselle Corbie-Smith
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

4.  Consumer Perspectives on Access to Direct-to-Consumer Genetic Testing: Role of Demographic Factors and the Testing Experience.

Authors:  Sarah E Gollust; Stacy W Gray; Deanna Alexis Carere; Barbara A Koenig; Lisa Soleymani Lehmann; Amy L McGUIRE; Richard R Sharp; Kayte Spector-Bagdady; N A Wang; Robert C Green; J Scott Roberts
Journal:  Milbank Q       Date:  2017-06       Impact factor: 4.911

5.  Hereditary nonpolyposis colorectal cancer family members' perceptions about the duty to inform and health professionals' role in disseminating genetic information.

Authors:  Rebecca D Pentz; Susan K Peterson; Beatty Watts; Sally W Vernon; Patrick M Lynch; Laura M Koehly; Ellen R Gritz
Journal:  Genet Test       Date:  2005

6.  A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic.

Authors:  Martin Pesl; Hana Verescakova; Linda Skutkova; Jana Strenkova; Pavel Krejci
Journal:  Orphanet J Rare Dis       Date:  2022-06-16       Impact factor: 4.303

7.  New phosphate langbeinites, K2MTi(PO4)3 (M = Er, Yb or Y), and an alternative description of the langbeinite framework.

Authors:  Stefan T Norberg
Journal:  Acta Crystallogr B       Date:  2002-09-24

8.  Beginning community engagement at a busy biomedical research programme: experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya.

Authors:  Vicki Marsh; Dorcas Kamuya; Yvonne Rowa; Caroline Gikonyo; Sassy Molyneux
Journal:  Soc Sci Med       Date:  2008-04-02       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.